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Abstract
Introduction:  Anaplastic thyroid carcinoma, which is one of the most aggressive, malignant
tumors in humans, results in an extremely poor prognosis despite chemotherapy and radiotherapy.
The present study was designed to evaluate therapeutic effects of radiation by glycerol on p53-
mutant anaplastic thyroid carcinoma cells (8305c cells). To examine the effectiveness of glycerol in
radiation induced lethality for anaplastic thyroid carcinoma 8305c cells, we performed colony
formation assay and apoptosis analysis.
Results: Apoptosis was analyzed with Hoechst 33342 staining and DNA ladder formation assay.
8305c cells became radiosensitive when glycerol was added to culture medium before X-ray
irradiation. Apoptosis was induced by X-rays in the presence of glycerol. However, there was little
apoptosis induced by X-ray irradiation or glycerol alone. The binding activity of whole cell extracts
to bax promoter region was induced by X-rays in the presence of glycerol but not by X-rays alone.
Conclusion: These findings suggest that glycerol is effective against radiotherapy of p53-mutant
thyroid carcinomas.
Background
Anaplastic thyroid carcinoma, which is a relatively un-
common malignancy comprising 5–14 % of thyroid can-
cers [1], is recognized as one of the most aggressive
malignant tumor in humans and fails to respond to the
available chemotherapeutic agents or radiation [2,3].
Most patients die within a year after diagnosis [4,5]. Thus,
the improvement of therapeutic effects is needed to re-
store chemo- and radiosensitivity to anaplastic thyroid
carcinomas which have a high frequency of mutant p53
(mp53). Recently, p53 gene therapy has been developed
[6–8] and applied to patients carrying mp53[9–11]. How-
ever, overexpression of wild-type p53 (wtp53) risks induc-
ing suppression of proliferation in normal cells as well as
targeted cancer cells. The suppression of proliferation of
blood cells possibly gives negative effects on the physical
condition of patients. Thus, there are still difficulties in
the clinical application of p53 gene therapy. We have re-
ported a new cancer therapy strategy against mp53 cancer
cells, i.e. chemical chaperon therapy. This therapy is based
on glycerol-mediated conformational change of mp53
molecules. The restoration of the normal function in
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mp53 leads to enhanced radiosensitivity and induction of
apoptosis [12]. Glycerol appears to confer wtp53 function
on mp53 [13]. The function of glycerol as a chemical
chaperone has been reported elsewhere [14,15]. This nov-
el tool for enhancing the radiosensitivity of cancer cells
bearing mp53 is worth investing as p53-targeted cancer
therapy, since p53 mutations are frequently found in hu-
man cancer cells [16,17]. In the present study, we report
the apoptotic effect of glycerol combined with radio-treat-
ment in anaplastic thyroid carcinoma cells carrying mp53.
Results
To evaluate the effectiveness of glycerol in radiation in-
duced lethality for anaplastic thyroid carcinoma 8305c
cells, we examined colony formation assay. As shown in
Fig. 1, when glycerol was added to culture medium before
X-ray irradiation at a final concentration of 0.6 M, 8305c
cells became about 3 times more X-ray-sensitive at the D10
dose. In contrast, there was no enhanced radiation sensi-
tivity observed in 8305c cells after the addition of 0.3 M
glycerol alone (data not shown). These results suggest that
glycerol has an ability to enhance the radiosensitivity of
8305c cells. Figure. 2A shows the time-course of the fre-
quency of X-ray induced apoptotic cells. Though the fre-
quency did not increase after X-ray irradiation without the
glycerol treatment, the frequency was augmented in a
time-dependent manner in the presence of glycerol. Typi-
cal apoptotic bodies detected by Hoechst 33342 staining
analysis are shown in Fig. 2C and 2D. The destruction of
nuclei was observed 48 h after X-ray irradiation, especially
with glycerol (Fig. 2D). Apoptotic bodies appeared at a
higher frequency in the presence of glycerol (Fig. 2D) than
in the absence of glycerol (Fig. 2C). Increased incidence of
apoptotic body was not observed after glycerol treatment
alone. We next examined the induction of DNA fragmen-
tation after X-ray irradiation using agarose gel electro-
phoresis of DNA extracted from 8305c cells (Fig. 3). Clear
DNA ladders in the nucleosomal size were observed 24–
48 h after X-ray irradiation combined with glycerol (Fig.
3A). However, a faint DNA ladder was observed 48 h after
X-ray irradiation alone (Fig. 3B). No DNA ladder was ob-
served 48 h after glycerol treatment alone (Fig. 3A) and
thereafter. These results indicate that glycerol sensitized
radiation-induced apoptosis in anaplastic thyroid carci-
noma in 8305c cells. DNA (p53 consensus sequence,
p53CON) binding activity of whole cell extracts from X-
ray (6 Gy) irradiated cells was analyzed with gel mobility-
shift assay (Fig. 4). Whole cell extracts from non-irradiat-
ed cells showed no DNA binding activity. Similarly, the
extracts from X-ray-irradiated cells showed no DNA bind-
ing activity 6 h after the irradiation. However, the extracts
from glycerol-treated cells showed DNA binding activity
and the binding activity was also observed in the extracts
from the cells irradiated with X-rays 6 h after the irradia-
tion.
Discussion
Recently, the mutation of p53 has been reported to play an
important role in anaplastic change in differentiated thy-
roid carcinomas [19,20]. Supporting this, 8305c cells
show a point mutation at codon 273 of the p53 gene. The
p53 gene plays a pivotal role in the pathway that controls
cell growth, proliferation and apoptosis [21–24]. The lack
of the p53-regulated pathway is a common feature in a
large number of tumors, suggesting that it may be central
to the pathogenesis of human cancers. We have recently
reported that the effectiveness by radiotherapy or hyper-
thermic therapy depends on p53-status in human squa-
mous cell carcinoma (SAS cells) [12,25]. That is, SAS cells
transfected with mp53 are more radiation or heat resistant
than neo control cells. The similar p53-dependent radio-
sensitivity has also been reported elsewhere [26]. The
present results may provide useful information for radio-
therapy of mp53 cancer cells.
The present observed X-ray sensitivity enhanced by glycer-
ol may result from the enhancement of p53-independent
X-ray-induced apoptosis. However, this presumption is
not possible from the following reason. We have reported
Figure 1
Clonogenic surviving fractions after X-ray. Opened circles,
without glycerol; Closed circles, with 0.6 M glycerol.Molecular Cancer 2002, 1 http://www.molecular-cancer.com/content/1/1/4
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that glycerol can restore wtp53 function to mp53 cancer
cells [12,13,27]. The present data in 8305c cells strongly
supports the chemical chaperone effect of glycerol. Glyc-
erol possibly enhanced X-ray-sensitivity in 8305c cells
through restoration of mp53 to wtp53 functions. The
present data from gel mobility-shift assay suggest that the
restoration is brought through conformational change of
mp53 to wtp53. The mp53 molecules from cells treated
with glycerol and X-rays might affect the transactivation of
p53-down stream genes, especially apoptosis-related
genes such as bax. In relation to this, we have reported that
glycerol has an ability to enhance bax expression in mp53
human glioblastoma cells through phosphorylation of
p53 at serine 15 by PI3-K family [28]. The conformational
change of mp53 might be induced by glycerol alone be-
cause the DNA binding activity of mp53 was restored after
glycerol treatment alone (Fig. 4). However, in this case,
the transcriptional activity of mp53 is not likely to be re-
stored. Possibly, the mp53 molecules from cells treated
with glycerol alone is not modified by X-ray-induced
phosphorylation or acetylation. Therefore, it seems that
the cells treated with glycerol alone did not show apopto-
sis, as shown in Fig. 2 and 3. We have previously reported
that the DNA binding activity of mp53 was almost not re-
stored after glycerol treatment alone in p53 mutated at co-
don 248 [12]. Therefore, the effect of glycerol on mp53
may depend on mutation site of p53 and amino acid se-
quence affecting its three-dimensional conformation.
This result suggests that the investigation of mutation site
of p53 is an important process for the cancer therapies
based on p53 status.
New strategy based on the functional restoration of mp53
is recently being developed. Recent studies have reported
new compounds which rescue mp53 conformation and
function [29,30]. The compounds can induce apoptosis in
mp53 human tumor cells through restoration of the tran-
scriptional transactivation function to mp53. The com-
pounds may serve as anticancer drugs targeting mp53.
Compared with these compounds, glycerol seems to be
the most hopeful molecule for cancer therapy, because it
has been widely used as a clinical reagent already.
Conclusions
The present study suggests that chemical chaperones, such
as a glycerol, are useful for radiotherapy of p53-mutant
thyroid carcinomas.
Methods
Cells
The cells used in this study were a human anaplastic thy-
roid carcinoma-derived cell line, 8305c bearing a point
mutation at codon 273 in the p53 gene [18]. 8305c cells
were obtained from JCRB (HSRRB, Osaka, Japan). Cells
were maintained in continuous culture at 37C in a 5 %
CO2 humidified atmosphere. Cells were grown in RPMI
1640 medium supplemented with 10% heat-inactivated
FBS. Penicillin (100 U/ml) and streptomycin (100 g/ml)
were added to the media.
Glycerol treatment
Glycerol was added into the culture medium at a final
concentration of 0.6 M at 48 h before irradiation by X-ray
Figure 2
The time course of apoptotic body detected with
Hoechst33342 staining after X-ray irradiation (6 Gy). A,
8305c cells were treated with (closed circles) or without
(opened circles) 0.6 M glycerol. B-D, photographs of apop-
totic body in 8305c cells. B, control; C, 48 h after X-ray irra-
diation alone; D, 48 h after X-ray irradiation combined with
0.6 M glycerol; Bars, 25 m.
Figure 3
DNA fragmentation detected with agarose gel electrophore-
sis of DNA extracted from X-ray (6 Gy) irradiated cells. A
and B represent with and without glycerol (0.6 M), respec-
tively. C, no irradiation; Lanes 12, 24. 36 and 48, incubation
periods (h) after X-ray irradiation. Lane M, øX174 DNA Hae
III fragments as size markers.Molecular Cancer 2002, 1 http://www.molecular-cancer.com/content/1/1/4
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source (MBR-1520R, Hitachi, Tokyo, Japan). Thereafter
the cells were incubated at 37C in the presence of glycerol
until sampling of apoptosis assay. For survival assay, the
medium with glycerol was changed to glycerol-free medi-
um after 10 h incubation and thereafter cells were incu-
bated for seven to ten days at 37C in glycerol free-
medium.
Cell survival assay
To measure the radiosensitivity of the cells, cell survival
after X-ray irradiation was measured by plating cells into
25 cm2 flasks containing medium. Thereafter, colonies
were rinsed with PBS, fixed with methanol, stained with
2% Giemsa solution (Merck, Woodbridge, NJ, USA). Col-
onies containing at least 50 cells were counted. Surviving
fractions were measured in 3 independent duplicate ex-
periments. Bars (standard errors) are shown when they ex-
ceed the symbols.
Analysis of apoptosis
We performed the Hoechst 33342 staining and the agar-
ose gel electorophoresis for analyses of apoptosis, using
the 8305c cells. Two or more independent experiments
were repeated. Induction of apoptosis was analyzed by de-
tection of apoptotic bodies and DNA fragmentation. To
detect apoptotic bodies, cells were fixed with 1% glutaral-
dehyde (Nacalai Tesque, Kyoto, Japan) in PBS at 4C,
washed with PBS, stained with 0.2 mM Hoechst 33342
(Sigma Chemical Co.), and then observed under a fluores-
cence microscope. Apoptotic bodies were counted at 3 dif-
ferent fields of the microscopic observation. One hundred
cells were judged under one field. For detection of DNA
fragmentation in the nucleosomal size range, cells were
suspended in lysis buffer containing 10 mM Tris-HCl, pH
7.4, 10 mM NaCl, 10 mM EDTA and 1% sodium N-lau-
roylsarcosinate, incubated with 100 g/ml protease K at
37C overnight, and then centrifuged at 18,500  g for 30
min. The resulting supernatants were incubated with 100
g/ml RNase A at 37C for 1 h. The DNA in the solution
was precipitated with ethanol at -20C, dissolved in 10
mM Tris-HCl, pH 8.0, and 1 mM EDTA, and electro-
phoresed for 30 min at 100 V through 3% NuSieve 3:1
gels containing 40 mM Tris-acetate, pH 7.8, 2 mM EDTA
and 0.5 g/ml ethidium bromide. After electrophoresis,
the gels were photographed under ultraviolet light.
Gel mobility-shift assay
Whole cell extracts were prepared from X-ray-irradiated or
non-irradiated cells (about 2  107 cells) according to the
method described elsewhere [12]. The binding activity of
p53 to p53 consensus sequence (p53CON) was measured
by a gel mobility-shift assay [12] using a synthetic double-
stranded DNA fragment encoding the p53CON (5'-GGA-
CATGCCCGGGCATGTCC-3', Japan Bioservice, Niiza,
Saitama, Japan) based on a specific sequence located up-
stream to the bax gene as a probe.
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